Persistent SARS-CoV-2-positive over 4 months in a COVID-19 patient with CHB
In recent months, the novel coronavirus disease 2019 (COVID-19) pandemic has become a major public health crisis with takeover more than 1 million lives worldwide. The long-lasting existence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has not yet been reported. Herein, we report...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
De Gruyter
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8ece37f7a0274aa893d3bd961bcbed90 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:8ece37f7a0274aa893d3bd961bcbed90 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:8ece37f7a0274aa893d3bd961bcbed902021-12-05T14:10:54ZPersistent SARS-CoV-2-positive over 4 months in a COVID-19 patient with CHB2391-546310.1515/med-2021-0283https://doaj.org/article/8ece37f7a0274aa893d3bd961bcbed902021-05-01T00:00:00Zhttps://doi.org/10.1515/med-2021-0283https://doaj.org/toc/2391-5463In recent months, the novel coronavirus disease 2019 (COVID-19) pandemic has become a major public health crisis with takeover more than 1 million lives worldwide. The long-lasting existence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has not yet been reported. Herein, we report a case of SARS-CoV-2 infection with intermittent viral polymerase chain reaction (PCR)-positive for >4 months after clinical rehabilitation. A 35-year-old male was diagnosed with COVID-19 pneumonia with fever but without other specific symptoms. The treatment with lopinavir-ritonavir, oxygen inhalation, and other symptomatic supportive treatment facilitated recovery, and the patient was discharged. However, his viral PCR test was continually positive in oropharyngeal swabs for >4 months after that. At the end of June 2020, he was still under quarantine and observation. The contribution of current antivirus therapy might be limited. The prognosis of COVID-19 patients might be irrelevant to the virus status. Thus, further investigation to evaluate the contagiousness of convalescent patients and the mechanism underlying the persistent existence of SARS-CoV-2 after recovery is essential. A new strategy of disease control, especially extending the follow-up period for recovered COVID-19 patients, is necessary to adapt to the current situation of pandemic.Li WenyuanHuang BeibeiShen QiangJiang ShouweiJin KunNing LingLiu LeiLi LeiDe Gruyterarticlecovid-19sars-cov-2convalescencecoronaviruscase reportMedicineRENOpen Medicine, Vol 16, Iss 1, Pp 749-753 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
covid-19 sars-cov-2 convalescence coronavirus case report Medicine R |
spellingShingle |
covid-19 sars-cov-2 convalescence coronavirus case report Medicine R Li Wenyuan Huang Beibei Shen Qiang Jiang Shouwei Jin Kun Ning Ling Liu Lei Li Lei Persistent SARS-CoV-2-positive over 4 months in a COVID-19 patient with CHB |
description |
In recent months, the novel coronavirus disease 2019 (COVID-19) pandemic has become a major public health crisis with takeover more than 1 million lives worldwide. The long-lasting existence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has not yet been reported. Herein, we report a case of SARS-CoV-2 infection with intermittent viral polymerase chain reaction (PCR)-positive for >4 months after clinical rehabilitation. A 35-year-old male was diagnosed with COVID-19 pneumonia with fever but without other specific symptoms. The treatment with lopinavir-ritonavir, oxygen inhalation, and other symptomatic supportive treatment facilitated recovery, and the patient was discharged. However, his viral PCR test was continually positive in oropharyngeal swabs for >4 months after that. At the end of June 2020, he was still under quarantine and observation. The contribution of current antivirus therapy might be limited. The prognosis of COVID-19 patients might be irrelevant to the virus status. Thus, further investigation to evaluate the contagiousness of convalescent patients and the mechanism underlying the persistent existence of SARS-CoV-2 after recovery is essential. A new strategy of disease control, especially extending the follow-up period for recovered COVID-19 patients, is necessary to adapt to the current situation of pandemic. |
format |
article |
author |
Li Wenyuan Huang Beibei Shen Qiang Jiang Shouwei Jin Kun Ning Ling Liu Lei Li Lei |
author_facet |
Li Wenyuan Huang Beibei Shen Qiang Jiang Shouwei Jin Kun Ning Ling Liu Lei Li Lei |
author_sort |
Li Wenyuan |
title |
Persistent SARS-CoV-2-positive over 4 months in a COVID-19 patient with CHB |
title_short |
Persistent SARS-CoV-2-positive over 4 months in a COVID-19 patient with CHB |
title_full |
Persistent SARS-CoV-2-positive over 4 months in a COVID-19 patient with CHB |
title_fullStr |
Persistent SARS-CoV-2-positive over 4 months in a COVID-19 patient with CHB |
title_full_unstemmed |
Persistent SARS-CoV-2-positive over 4 months in a COVID-19 patient with CHB |
title_sort |
persistent sars-cov-2-positive over 4 months in a covid-19 patient with chb |
publisher |
De Gruyter |
publishDate |
2021 |
url |
https://doaj.org/article/8ece37f7a0274aa893d3bd961bcbed90 |
work_keys_str_mv |
AT liwenyuan persistentsarscov2positiveover4monthsinacovid19patientwithchb AT huangbeibei persistentsarscov2positiveover4monthsinacovid19patientwithchb AT shenqiang persistentsarscov2positiveover4monthsinacovid19patientwithchb AT jiangshouwei persistentsarscov2positiveover4monthsinacovid19patientwithchb AT jinkun persistentsarscov2positiveover4monthsinacovid19patientwithchb AT ningling persistentsarscov2positiveover4monthsinacovid19patientwithchb AT liulei persistentsarscov2positiveover4monthsinacovid19patientwithchb AT lilei persistentsarscov2positiveover4monthsinacovid19patientwithchb |
_version_ |
1718371615692029952 |